Breaking News: Expert Perspective on Venclexta (venetoclax) Approval

The U.S. Food and Drug Administration (FDA) has approved a new drug Venclexta (venetoclax) for use in CLL patients with the 17p deletion. Andrew Schorr interviewed CLL expert Dr. Thomas Kipps to get h... Author: patientpower Added: 04/13/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts